Ledger.Open graph →
SEC Form D · filed October 17, 2014

AgeneBio, Inc

Offering
$10.0M
Sold
$4.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Michela W. Gallagher · BALTIMORE, MDExec · DirectorCharles W. Clarvit · BALTIMORE, MDDirectorGerald W. Mclaughlin · BALTIMORE, MDExec · DirectorRonald W. Nordmann · BALTIMORE, MDDirectorFloyd W. Bloom · BALTIMORE, MDDirectorPatrick W. Lepore · BALTIMORE, MDDirectorSharon W. Rosenzweig-Lipson · BALTIMORE, MDExecShirley T. Hong · MAPLETREE BUSINESS CITY, U0DirectorWan K. Weng · MAPLETREE BUSINESS CITY, U0Exec · DirectorChua T. Chye · MAPLETREE BUSINESS CITY, U0DirectorPennant General Partner, L.L.C · Summit, NJExec · DirectorWilliam T. Mckee · Princeton, NJExec · DirectorJohn S. Hubbard · Princeton, NJDirectorScott M. Coiante · Princeton, NJExec · DirectorAl Altomari · Princeton, NJDirectorAbhijeet P. Lele · Princeton, NJDirectorElizabeth M. Garner · Princeton, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗